Skip to content
healthcare.dev

SUPREME ANTACID

NDC 55319-624, calcium carbonate, magnesium hydroxide, suspension, from FAMILY DOLLAR SERVICES INC.

Product NDC
55319-624
Status
Listed
Labeler
FAMILY DOLLAR SERVICES INC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55319-624 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIUM CARBONATE400 mg/5mL
  • MAGNESIUM HYDROXIDE135 mg/5mL

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
55319-624-1255319062412355 mL in 1 BOTTLE (55319-624-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55319-624 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55319-624 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55319-624. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.